Company news
Endonovo Therapeutics, Inc. (OTC:ENDV) news
Endonovo Therapeutics, Inc. news releases on 6ix. Latest, Oct 13, 2017: Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive…
Press releases — page 3
Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical
October 13, 2017
Endonovo Therapeutics Provides Update on Pre-Clinical Studies
September 26, 2017
Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit
September 22, 2017
Endonovo Therapeutics Issues Open Letter and Update to Its Shareholders
June 29, 2017
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Kidney Disease
June 1, 2017
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Non-Alcoholic Steatohepatitis (NASH)
May 11, 2017
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical Device for Treatment of Critical Limb Ischemia
May 4, 2017
Endonovo Therapeutics Files a New Patent Application on Method to Treat Tissues and Organs Using Its Non-Invasive Electroceutical Technology
March 23, 2017
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical Device Following Myocardial Infarction
December 19, 2016
Endonovo Signs Term Sheet for $5 Million to Redeem All Outstanding Convertible Notes and Prepare to Uplist Its Common Stock
November 28, 2016
Endonovo (ENDV) Benefits from NASH Buying Spree -- SECFilings.com
November 21, 2016
How New Technologies Could Revolutionize Drug Discovery -- SECFilings.com
November 14, 2016
Endonovo Therapeutics (ENDV): Targeting $20+ Billion Market for In Vitro ADME and Toxicology Testing
November 7, 2016
The Non-Invasive Advantage of Endonovo Therapeutics' (OTCQB: ENDV) Electroceuticals -- SECFilings.com
October 28, 2016
SECFilings Releases Report on Why Bioelectronics are the Future of Medicine
October 18, 2016
Endonovo Therapeutics Announces Registration Statement on Form S-1 has been Declared Effective
October 18, 2016
SECFilings Releases Report on Biotech Companies Targeting Liver Disease
October 7, 2016
Endonovo at the Intersection of Stem Cells and Biologics for Next Generation Therapeutics - SECFilings.com
September 29, 2016
Endonovo Establishing Its Footprint in Non-Invasive Bioelectronic Medicine Space -- SECFilings.com
September 15, 2016
Endonovo Therapeutics Receives Notice of Termination of Its Binding-Letter Agreement to Acquire Rio Grande Neurosciences
August 19, 2016
Endonovo Therapeutics Files Patent for Treating Chemical and Radiation Injuries Using Next-Generation Biologics
August 10, 2016
Endonovo Therapeutics Announces Issuance of U.S. Patent on Production of Human Biomolecules
August 9, 2016
Endonovo Therapeutics Announces New Round of Financing
July 15, 2016
Endonovo Therapeutics Announces Binding Letter of Intent to Acquire Rio Grande Neurosciences, Inc.
July 11, 2016
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
June 29, 2016
Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al
June 23, 2016
Endonovo Therapeutics Provides Update on Variable Convertible Notes
June 15, 2016
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
May 31, 2016
Endonovo Therapeutics to Present at the 2016 Marcum Microcap Conference in New York
May 5, 2016
Endonovo Therapeutics to Present at the SeeThruEquity 5th Annual Microcap Investor Conference in New York
April 13, 2016
Endonovo Therapeutics Receives USPTO Notice of Allowance for Patent Covering Production of Biomolecules From Adult Stem Cells
March 30, 2016
Endonovo Therapeutics Provides Corporate Update and 2016 Outlook
March 14, 2016
Endonovo Therapeutics Retains Holland & Knight to File for Orphan Drug Designation
February 11, 2016
Endonovo Therapeutics Buys Back Convertible Note From Lender Avoiding Any Immediate Dilution
December 11, 2015
Endonovo Therapeutics Developing Next-Generation Cell Therapy for Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing Cytotronics Platform
November 3, 2015
Endonovo Therapeutics Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform
October 29, 2015
Endonovo Therapeutics Announces Immunotronic and Cytotronic Platforms
October 6, 2015
Endonovo Therapeutics Announces Method for Large Scale Expansion of Cord Blood
October 1, 2015
Endonovo Therapeutics Announces Corporate Patent Licensing Program
September 16, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – June 5
June 5, 2015